CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Insurance INS
Issues related to employer, small group and individual insurance markets, including surprise billing and ACA subsidies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| ROBERT TANNER WARBINTON | — |
Labor Issues/Antitrust/Workplace LBR
Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Pharmacy PHA
Issues related to drug pricing transparency, women's health, and COVID-19 testing, vaccination and treatment. H.R. 1770, The Equitable Community Access to Pharmacist Services Act S. 2477, The Equitable Community Access to Pharmacist Services Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Taxation/Internal Revenue Code TAX
Issues related to the corporate tax rate.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNON PENBERTHY | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to COVID testing, vaccination, and treatment. Issues related to Accountable Care Organization. Issues related to Medicare Shared Savings Program. S. 1339 - Pharmacy Benefit Manager Reform Act of 2023 S. 1967 - Patients Before Middlemen Act of 2023 S. 2973 - Modernizing and Ensuring PBM Accountability (MEPA) Act S. 3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R. 2679 - Pharmacy Benefit Manager Accountability Act of 2023 H.R. 3285 - Fairness for Patient Medications Act H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 H.R. 3561 - Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 H.R. 5378 - Lower Costs, More Transparency Act H.R. 2880 - Protecting Patients Against PBM Abuses Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE BURDA | — |
| ROBERT BUTORA | — |
| KAITLYN LANE | — |
| YUJIN LEE | — |
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| AMY ROSENBAUM | — |
| MELISSA SCHULMAN | — |
| ROBERT TANNER WARBINTON | — |
Consumer Issues/Safety/Products CSP
Issues related to organized retail crime and consumer safety. S. 139 - The Organized Retail Crime Center Authorization Act of 2023 S. 140 - The Combatting Organized Retail Crime Act of 2023 H.R. 895 - The Combatting Organized Retail Crime Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOY MCGLAUN | — |
| SHANNON PENBERTHY | — |
| ROBERT TANNER WARBINTON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.